Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$54.2 - $69.69 $404,115 - $519,608
7,456 New
7,456 $515,000
Q1 2020

Apr 21, 2020

SELL
$30.35 - $67.14 $119,275 - $263,860
-3,930 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$55.65 - $79.83 $46,356 - $66,498
-833 Reduced 17.49%
3,930 $242,000
Q3 2019

Nov 07, 2019

SELL
$64.7 - $85.39 $8,022 - $10,588
-124 Reduced 2.54%
4,763 $347,000
Q2 2019

Aug 06, 2019

SELL
$67.77 - $82.2 $28,802 - $34,935
-425 Reduced 8.0%
4,887 $402,000
Q1 2019

May 06, 2019

SELL
$45.83 - $70.54 $439,555 - $676,549
-9,591 Reduced 64.36%
5,312 $375,000
Q4 2018

Feb 11, 2019

BUY
$41.17 - $56.44 $123,427 - $169,207
2,998 Added 25.18%
14,903 $671,000
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $76,777 - $103,443
1,450 Added 13.87%
11,905 $673,000
Q2 2018

Aug 14, 2018

SELL
$56.38 - $68.08 $223,546 - $269,937
-3,965 Reduced 27.5%
10,455 $698,000
Q1 2018

May 14, 2018

SELL
$56.98 - $72.41 $401,253 - $509,911
-7,042 Reduced 32.81%
14,420 $840,000
Q4 2017

Feb 14, 2018

SELL
$53.3 - $74.56 $81,442 - $113,927
-1,528 Reduced 6.65%
21,462 $1.38 Million
Q3 2017

Nov 13, 2017

BUY
$43.46 - $52.49 $781,236 - $943,560
17,976 Added 358.52%
22,990 $1.21 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,014
5,014 $235,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $973M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.